Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 13, 2022

50715_rns_2022-06-13_21a7bbdc-d253-427f-a7ff-320dcb7720ae.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

13 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Descriptionof products Nature ofdealings Number ofreferencesecurities towhich thederivativesrelate Maturitydate /closing outdate Referenceprice Total amountpaid / received Resultantbalance(includingthose of anyperson withwhom there isan agreementorunderstanding)
CICC PuchengInvestment Co.,Ltd. 10 June2022 Derivatives Other types ofproducts Closing out of aderivative contract 4,000 19 February2025 $28.2000 $112,800.0000 74,000
Derivatives Other types ofproducts Closing out of aderivative contract 6,000 22 May 2024 $28.2000 $169,200.0000 58,000
Derivatives Other types ofproducts Closing out of aderivative contract 4,000 14 June 2023 $28.2530 $113,011.8900 74,000

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Derivatives Other types ofproducts Closing out of aderivative contract 6,000 14 June 2023 $28.2530 $169,517.8400 58,000

End

Note:

CICC Pucheng Investment Co., Ltd. is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

CICC Pucheng Investment Co., Ltd. is ultimately owned by China International Capital Corporation Limited.